AUPM678294A0 - Use of insulin-like growth factor in combination with insulin - Google Patents

Use of insulin-like growth factor in combination with insulin

Info

Publication number
AUPM678294A0
AUPM678294A0 AUPM6782A AUPM678294A AUPM678294A0 AU PM678294 A0 AUPM678294 A0 AU PM678294A0 AU PM6782 A AUPM6782 A AU PM6782A AU PM678294 A AUPM678294 A AU PM678294A AU PM678294 A0 AUPM678294 A0 AU PM678294A0
Authority
AU
Australia
Prior art keywords
insulin
combination
growth factor
growth
factor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPM6782A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medvet Science Pty Ltd
Novozymes Biopharma AU Ltd
Original Assignee
Gropep Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gropep Ltd filed Critical Gropep Ltd
Priority to AUPM6782A priority Critical patent/AUPM678294A0/en
Publication of AUPM678294A0 publication Critical patent/AUPM678294A0/en
Priority to PCT/AU1995/000422 priority patent/WO1996002270A1/en
Priority to AU29174/95A priority patent/AU2917495A/en
Assigned to GROPEP PTY LTD, MEDVET SCIENCE PTY. LTD. reassignment GROPEP PTY LTD Assignment by Applicant under S 113 Assignors: GROPEP PTY LTD
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/30—Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2
AUPM6782A 1994-07-13 1994-07-13 Use of insulin-like growth factor in combination with insulin Abandoned AUPM678294A0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AUPM6782A AUPM678294A0 (en) 1994-07-13 1994-07-13 Use of insulin-like growth factor in combination with insulin
PCT/AU1995/000422 WO1996002270A1 (en) 1994-07-13 1995-07-13 Use of insulin-like growth factor in combination with insulin
AU29174/95A AU2917495A (en) 1994-07-13 1995-07-13 Use of insulin-like growth factor in combination with insulin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPM6782A AUPM678294A0 (en) 1994-07-13 1994-07-13 Use of insulin-like growth factor in combination with insulin

Publications (1)

Publication Number Publication Date
AUPM678294A0 true AUPM678294A0 (en) 1994-08-04

Family

ID=3781339

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPM6782A Abandoned AUPM678294A0 (en) 1994-07-13 1994-07-13 Use of insulin-like growth factor in combination with insulin

Country Status (2)

Country Link
AU (1) AUPM678294A0 (en)
WO (1) WO1996002270A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9402331D0 (en) * 1994-07-01 1994-07-01 Pharmacia Ab New use
US5868728A (en) * 1995-02-28 1999-02-09 Photogenesis, Inc. Medical linear actuator for surgical delivery, manipulation, and extraction
US5783556A (en) * 1996-08-13 1998-07-21 Genentech, Inc. Formulated insulin-containing composition
CA2369839A1 (en) 1999-06-25 2001-01-04 Minimed, Inc. Compositions of insulin and insulin-related peptide for treating diabetes
GB2369572A (en) 2000-11-29 2002-06-05 Raft Trustees Ltd Wound treatment composition comprising insulin
WO2002067969A2 (en) 2001-02-21 2002-09-06 Medtronic Minimed, Inc. Stabilized insulin formulations
US6737401B2 (en) 2001-06-28 2004-05-18 Metronic Minimed, Inc. Methods of evaluating protein formulation stability and surfactant-stabilized insulin formulations derived therefrom
WO2008079324A1 (en) * 2006-12-21 2008-07-03 Boston Biomedical Research Institute Immunological modulation of insulin-like growth factor 1 for cancer prevention/treatment and prolonging longevity
US20110045056A1 (en) 2008-01-17 2011-02-24 First Water Limited Hydrogel co-polymer composition and its uses, for example as a wound dressing
GB0905290D0 (en) 2009-03-27 2009-05-13 First Water Ltd Multilayer compositions and dressings
GB201318842D0 (en) 2013-10-24 2013-12-11 First Water Ltd Flexible hydrogel wound dressings

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5091173A (en) * 1989-06-29 1992-02-25 The University Of Dundee Hair growth composition
DK0586589T3 (en) * 1991-05-24 1997-09-22 Amylin Pharmaceuticals Inc Amylin or amylin analogue, possibly containing insulin, for the treatment of anorexia and related conditions
US5202119A (en) * 1991-06-28 1993-04-13 Genentech, Inc. Method of stimulating immune response
JPH0543453A (en) * 1991-08-20 1993-02-23 Sumitomo Pharmaceut Co Ltd Local sustained-release preparation for accelerating wound curing
HUT67319A (en) * 1991-08-30 1995-03-28 Life Medical Sciences Inc Compositions for treating wounds
CH684573A5 (en) * 1991-11-25 1994-10-31 Inst Molecular Biology Inc The use of growth factors for producing a pharmaceutical composition for promoting growth of mammalian nerves
DE4208552A1 (en) * 1992-03-17 1993-09-23 Liedtke Pharmed Gmbh TOPICAL MEDICINE FORMS WITH INSULIN
ES2174852T3 (en) * 1992-08-26 2002-11-16 Celtrix Pharma METHOD FOR THE SYSTEMIC TREATMENT OF CATABOLIC STATES AND SYSTEMS INJURIES OF FABRICS.
AU6093794A (en) * 1993-01-29 1994-08-15 Synergen, Inc. Wound healing composition

Also Published As

Publication number Publication date
WO1996002270A1 (en) 1996-02-01

Similar Documents

Publication Publication Date Title
IL128128A (en) Composition comprising insulin and insulin-like growth factor (i-igf)
AU2601895A (en) Modified insulin-like growth factors
AUPM348594A0 (en) Improvements in syringe pumps
AU5100793A (en) Wheelchair with convertible seat-stretcher
AU3482495A (en) Substituted heteroaromatic compounds and their use in medicine
US5507832B1 (en) Prosthesis with integral proximal spacer
AU4725793A (en) Schwann cell mitogenic factor, its preparation and use
AU1868595A (en) Human growth hormone
AU2511295A (en) Dual barrel syringe and method of use
AU2473195A (en) Single use syringes
AU1081292A (en) New beta-amino- alpha-hydroxycarboxylic acids and their use
AU7319994A (en) Nucleotide preparation and uses thereof in wound healing
AU2630295A (en) 2-acylaminopropanol compound and medical composition
AU2525092A (en) Combination containing growth factors and polyelectrolytes
AUPM678294A0 (en) Use of insulin-like growth factor in combination with insulin
AU3574593A (en) Hair growth and restoration promoter
AU1908095A (en) The use of mannan-rich materials in feedstuffs
GB9412629D0 (en) Improvements in crystal growth
AU2940895A (en) Use of insulin and igf-i
AU1942995A (en) New use of growth hormone
AU5773794A (en) 4-amino-3-hydroxycarboxylic acid and their use as anitvirals
AU2917495A (en) Use of insulin-like growth factor in combination with insulin
AU1401495A (en) Human vascular ibp-like growth factor
AU658314B2 (en) Growth promotion in swine
AU9293598A (en) The use of insulin-like growth factor-i in muscle